Company Name: Syndax Pharmaceuticals, Inc.    

Syndax Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. The company is engaged in the development of cancer treatments. The company’s focus is on its product candidate entinostat, a combination therapeutic for several cancers (initial focus is on tumors sensitive to immunotherapy).

Ticker Symbol: SNDX (NASDAQ)

Company Website:

Headquarters: Waltham, Massachusetts